Audited annual filings, TTM ratios and consensus forward estimates
Wall Street price targets and rating actions
Revenue disaggregation per 10-K filing
Annual filings (FY) with consensus forward estimates (hatched)
1234 daily bars · split adjusted
Current price $1.74
Latest analyst grade actions
| Date | Firm | Action | Previous | New grade |
|---|---|---|---|---|
| Aug 13, 25 |
Daily · Wilder smoothing
| JMP Securities |
| downgrade |
| Market Outperform |
| Market Perform |
| Mar 31, 25 | HC Wainwright & Co. | maintain | Neutral | Neutral |
| Mar 31, 25 | Citizens Capital Markets | maintain | Market Outperform | Market Outperform |
| Nov 13, 24 | HC Wainwright & Co. | downgrade | Buy | Neutral |
| Sep 16, 24 | JMP Securities | maintain | Market Outperform | Market Outperform |
| May 23, 24 | JMP Securities | maintain | Market Outperform | Market Outperform |
| May 15, 24 | HC Wainwright & Co. | maintain | Buy | Buy |
| Mar 28, 24 | JMP Securities | maintain | Market Outperform | Market Outperform |
| Mar 27, 24 | HC Wainwright & Co. | maintain | Buy | Buy |
Classic floor pivots from 2026-09-24
Computed from daily OHLCV bars
| Indicator | Value | Type | Action |
|---|---|---|---|
| RSI (14) | 40.45 | Oscillator | Neutral |
| Stochastic %K (14, 3, 3) | 37.86 | Oscillator | Neutral |
| Williams %R (14) | -70.00 | Oscillator | Neutral |
| MACD (12, 26, 9) | -0.29 (Hist 0.07) | Oscillator | Buy |
| Average Directional Index (14) | 21.06 (+DI 16.9 / -DI 16.4) | Trend | Buy |
| EMA 20 | 1.87 | MA | Strong Sell |
| SMA 20 | 1.62 | MA | Strong Sell |
| EMA 50 | 2.54 | MA | Strong Sell |
| SMA 50 | 2.68 | MA | Strong Sell |
| SMA 200 | 8.99 | MA | Strong Sell |
TTM vs. 5-year historical average (annual ratios)
| Metric | BCAB | Historical (5Y) / ref | Status |
|---|---|---|---|
| P/E ratio (TTM) | -0.1x | -2.4x · sector 20.7x | Discount |
| Forward P/E (FY26E) | -0.0x | EPS est. -46.00 | Discount |
| Price / Book | -0.1x | 1.6x | Discount |
| Price / Sales | 0.3x | 546.6x | Discount |
| EV / EBITDA | -0.2x | -1.2x | Discount |
| Return on equity | 89.2% | — | Top tier |
| Gross margin | 100.0% | -5034.3% | Below hist. |
| Debt / Equity | -0.16 | -0.01 | Conservative |
| Piotroski / Altman Z | 4/9 | Z -93.50 | Distress |
Discounted cash flow model
Stock news · updated daily
Reported EPS vs. consensus estimate
| Report date | EPS est. | EPS actual | Surprise | Revenue |
|---|---|---|---|---|
| Aug 13, 2026 | -8.50 | 0.27 | Beat 103.2% | $6.50M |
| May 15, 2026 | -10.00 | -6.18 | Beat 38.2% | — |
| Mar 31, 2026 | -12.00 | -8.00 | Beat 33.3% | $2.00M |
| Nov 13, 2025 | -0.31 | -13.50 | Miss -4254.8% | — |
| Aug 7, 2025 | -0.29 | -16.00 | Miss -5354.6% | — |
| May 6, 2025 | -0.29 |
| -13.00 |
| Miss -4331.9% |
| — |
Free float vs. closely held shares
13F institutional holdings are not available in the current data plan.
SEC Form 4 filings
| Date | Insider | Role | Type | Shares @ price | Value |
|---|---|---|---|---|---|
| Aug 31, 26 | Sievers Eric | officer: Chief Medical Officer | F-InKind | 134 @ $1.69 | $226 |
| Aug 31, 26 | Short Jay M Phd | director, officer: Chief Executive Officer | F-InKind | 259 @ $1.69 | $438 |
| Aug 31, 26 | Vasquez Christian | officer: Chief Financial Officer | F-InKind | 71 @ $1.69 | $120 |
| Mar 11, 26 | Vasquez Christian | officer: Chief Financial Officer | F-InKind | 175 @ $0.169 | $30 |
| May 31, 26 | Vasquez Christian | officer: Chief Financial Officer | F-InKind | 82 @ $3.93 | $322 |
| Mar 12, 26 | Short Jay M Phd | director, officer: Chief Executive Officer | F-InKind | 639 @ $0.168 | $107 |
| May 31, 26 | Short Jay M Phd | director, officer: Chief Executive Officer | F-InKind | 259 @ $3.93 | $1.02K |
| May 31, 26 | Sievers Eric | officer: Chief Medical Officer | F-InKind | 134 @ $3.93 | $527 |
| 4 | Sep 2, 2026 | 2026-09-02 17:27:39 | View |
| 4 | Sep 2, 2026 | 2026-09-02 17:26:53 | View |
| 8-K | Aug 28, 2026 | 2026-08-28 08:01:39 | View |
| 10-Q | Aug 13, 2026 | 2026-08-13 17:00:44 | View |
| 8-K | Jul 16, 2026 | 2026-07-16 16:12:27 | View |
| 4 | Jun 5, 2026 | 2026-06-05 16:30:18 | View |
Proxy statement (DEF 14A) disclosures